Core Scientific, Inc.

Based on a comprehensive analysis of CORZ, the evidence strongly argues against a purchase at this time.

Technical Outlook: While the stock has recovered significantly from its lows, recent weakness and a history of extreme volatility (beta of 6.885) and sharp drawdowns make it a highly unpredictable holding. Its current price in the upper-mid range offers limited margin of safety from a technical perspective.

Fundamental & Valuation Concerns: The fundamentals are deeply troubling, with severely negative profit margins, weak cash flow relative to debt, and poor operational efficiency. The company's negative earnings render standard valuation metrics meaningless, and the lack of peer data prevents any meaningful assessment of its relative value.

Considering the extreme volatility, unsustainable financial performance, and inability to determine a fair value, CORZ presents a high-risk, speculative profile with no clear fundamental anchor. The recommendation is to avoid this stock. Investors should seek opportunities with more stable financials and clearer valuation prospects.

RockFlow Model Forecast: Three Scenarios for 2026

Based on a comprehensive analysis, the 12-month outlook for CORZ is highly speculative due to its unstable foundation. The key catalyst for any significant price appreciation would likely be a major, unexpected turnaround in its core operations leading to positive cash flow, though this appears unlikely given the current weak fundamentals. The potential risks are substantial, dominated by its extreme volatility (beta near 7.0), persistently negative earnings, and weak cash flow relative to debt, which could lead to sharp declines on any negative news. With no analyst target price available and an inability to determine a fair value, the stock is best avoided by all but the most risk-tolerant speculators.

Wall Street Consensus

Most Wall Street analysts are optimistic about Core Scientific, Inc.'s 12-month outlook, with consensus target around $17.84, indicating expected upside potential.

Overall, CORZ has investment potential but also faces challenges. Here are key factors to weigh before investing.

CORZ has demonstrated significant volatility with substantial gains from its 52-week low but recent weakness. The stock's extreme beta of 6.885 underscores its highly volatile nature compared to the broader market.

Short-term performance shows minor weakness over one month (-0.45%) but significant underperformance over three months (-7.52%), lagging the market by -7.57% during that period. This reflects a more pronounced recent downward trend despite the stock's high volatility profile.

Currently trading at $17.84, CORZ sits approximately 70% above its 52-week low but 25% below its high, positioning it in the upper-mid range of its yearly spectrum. While not at extreme levels presently, the stock's history of a -48.43% maximum drawdown highlights its potential for sharp corrections.

Revenue & Profitability: CORZ shows concerning revenue quality with a gross profit margin of just 4.7% in Q3 2025, indicating minimal markup over direct costs. Both operating and net income margins are deeply negative (-80.7% and -180.8% respectively), reflecting significant operational inecurities and unsustainable profitability despite slight sequential revenue growth from Q2.

Financial Health: The company maintains a reasonable current ratio of 1.58, suggesting adequate short-term liquidity. However, the cash flow to debt ratio of 0.12 is weak, and the negative enterprise value multiple signals substantial market concerns about the company's overall debt-bearing capacity and enterprise valuation.

Operational Efficiency: CORZ exhibits severely poor operational performance with a negative return on capital employed (-4.0%) and a very low asset turnover of 0.035, indicating ineffective use of assets to generate revenue. The positive ROE of 13.0% appears distorted, likely driven by a significantly negative equity base rather than genuine operational performance.

Valuation Level The stock cannot be meaningfully assessed on conventional PE or PB ratios, as both metrics are negative due to the company reporting losses rather than profits or net income. This negative earnings profile extends to its EV/EBITDA, indicating significant negative operational cash flow and rendering standard valuation metrics useless for determining an overvalued or undervalued status. The only potentially positive sign is a negative PEG ratio, which could suggest growth expectations are high relative to current losses, but this metric is notoriously unreliable when earnings are negative.

Peer Comparison A peer comparison cannot be performed as industry average data is unavailable. In the absence of this contextual data, it is impossible to determine how CORZ's negative valuation metrics compare to its sector competitors. The analysis is therefore limited to concluding that the company is in a loss-making position without the ability to benchmark the scale of these losses against its industry.

Volatility Risk CORZ demonstrates extreme volatility risk, as evidenced by its exceptionally high beta of 6.885, which indicates the stock is significantly more volatile than the broader market. This is further validated by the substantial one-year maximum drawdown of -48.43%, highlighting pronounced downside risk and susceptibility to severe price swings during market downturns.

Other Risks While the stock exhibits no short interest, which suggests a lack of active bearish sentiment, its high volatility inherently increases trading risks. The combination of extreme price movements and potentially concentrated ownership could negatively impact liquidity, making it difficult to execute large orders without affecting the share price.